NCT01968317
Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma treatment 2 completed NCT05675787
Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia treatment 2 recruiting NCT02397083
Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer treatment 2 active_not_recruiting NCT03671811
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy treatment 2 active_not_recruiting NCT05316493
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia treatment 2 / 3 recruiting NCT00788671
Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer No drug interventions treatment 2 active_not_recruiting NCT03241888
Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia treatment 2 / 3 completed NCT05647109
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer No drug interventions Not Available Not Available recruiting NCT04683237
Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia treatment 2 / 3 withdrawn NCT03463252
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC treatment 2 / 3 recruiting NCT04607252
Metformin Plus Megestrol Acetate as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia treatment 2 / 3 terminated NCT05172999
Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia treatment 2 / 3 recruiting NCT06379113
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients treatment 2 / 3 recruiting NCT05051722
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer No drug interventions Not Available Not Available recruiting NCT04491682
Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia treatment 2 / 3 completed NCT06390904
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients No drug interventions treatment 2 / 3 recruiting NCT00490087
Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women No drug interventions treatment 3 completed NCT01943058
Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer No drug interventions treatment 2 withdrawn NCT05316935
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients No drug interventions treatment 2 / 3 recruiting NCT00892866
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells No drug interventions other Not Available active_not_recruiting NCT00483327
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate No drug interventions treatment 2 completed NCT04385667
LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia No drug interventions treatment 2 / 3 completed